Journal
DRUG DEVELOPMENT RESEARCH
Volume 78, Issue 8, Pages 403-410Publisher
WILEY
DOI: 10.1002/ddr.21412
Keywords
chondrocyte; CoQ10; IL-1; MAPKs; osteoarthritis
Categories
Funding
- Guangdong Natural Science Foundation [2016A030313259]
- Startup Foundation for Doctors of the Guangdong Natural Science Foundation [2015A030310451]
Ask authors/readers for more resources
Osteoarthritis (OA) is a widely prevalent degenerative joint disease that severely impairs the health of the elderly population resulting in a heavy economic burden worldwide. Coenzyme Q10 (CoQ10) has shown anti-inflammatory effects in some diseases. The present study aimed to investigate if CoQ10 would suppress catabolic responses of interleukin (IL)-1-induced chondrocytes. Rat chondrocytes were cultured and pretreated with CoQ10, and then stimulated with or without IL-1 (10 ng/ml). The expression and production of matrix metalloproteinase (MMP)-3, MMP-9, and MMP13 were determined using real-time PCR and Western blotting. CoQ10 suppressed MMP-3, MMP-9, and MMP13 production induced by IL-1, and markedly inhibited IL-1-induced MAPK pathways in rat chondrocytes. The present study provides insight into potential mechanisms by which CoQ10 protects against degeneration of cartilage in patients with OA, which may lead to new approaches for the treatment of OA.Drug Dev Res 78 : 403-410, 2017. (c) 2017 Wiley Periodicals, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available